Puregraf 75 IU Injection (Menotrophin)
| Active Ingredient | Menotrophin |
|---|---|
| Manufacturers | Gufic Biosciences Ltd. |
| Indications | Female infertility |
| Strength | 75iu |
| Packaging | 1 Injection in 1 vial |
| Delivery Time | 6 To 15 days |
Puregraf 75 IU Injection contains Menotrophin, a highly effective fertility hormone that includes both Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). It is commonly used in the treatment of female infertility by stimulating the growth and maturation of ovarian follicles, especially in women undergoing assisted reproductive technologies like IVF or IUI.
In men, Puregraf is used to treat hypogonadotropic hypogonadism, a condition where the body doesn’t produce enough hormones to support healthy sperm development. By enhancing both FSH and LH levels, it aids in improving sperm count and motility.
The injection is administered subcutaneously or intramuscularly, depending on your healthcare provider’s guidance. Treatment must be closely monitored using ultrasound and hormone blood tests to adjust dosage and minimize side effects.
Common side effects may include mild abdominal pain, bloating, headache, or injection site irritation. In women, there is a potential risk of Ovarian Hyperstimulation Syndrome (OHSS), especially with higher doses.
Puregraf 75 IU is a trusted option for couples struggling with infertility, offering support for both natural conception and advanced fertility procedures.








There are no reviews yet.